The performance of anti–cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: Results from the Norfolk Arthritis Register

OBJECTIVE: Anti–cyclic citrullinated peptide (anti-CCP) antibodies are a stronger predictor of the severity of rheumatoid arthritis than is rheumatoid factor (RF). Their role in predicting outcome in unselected patients with new-onset inflammatory polyarthritis (IP) has not been examined. The aims o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, M, Thomson, W, Naseem, H, Bunn, D, Silman, A, Symmons, D, Barton, A
Formato: Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2007
Materias:
Rheumatoid Arthritis Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435419/
https://www.ncbi.nlm.nih.gov/pubmed/17763407
http://dx.doi.org/10.1002/art.22868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435419/
https://www.ncbi.nlm.nih.gov/pubmed/17763407
http://dx.doi.org/10.1002/art.22868

Ejemplares similares